New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS

New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS

Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measure...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese Journal of Cardiovascular Surgery 2011/01/15, Vol.40(1), pp.31-33
Hauptverfasser: Akasu, Koji, Mori, Ryusuke, Ueda, Tomohiro, Tomoeda, Hiroshi, Arinaga, Koichi, Fukunaga, Shuji, Aoyagi, Shigeaki
Format: Artikel
Sprache:jpn
Schlagworte:
anticoagulation therapy
CoaguChek XS
PT-INR
Toyobo-LVAS
warfarin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was Y=0.8027X+0.3399. In addition, drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients.
ISSN:0285-1474
1883-4108
DOI:10.4326/jjcvs.40.31